Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT07289321
NA

Tramadol / Magnesium in Ropivacaine Solution in UG-bilateral TAP Block and Analgesia in Robotic Radical Prostatectomy

Sponsor: Aretaieion University Hospital

View on ClinicalTrials.gov

Summary

Tramadol and magnesium have already been researched in recent decades for their different roles in pain control. This clinical study will compare and re-evaluate their effect on the duration and quality of analgesia provided by a regional anesthesia technique. Participants will be men aged 40 to 80 years with prostate cancer who are scheduled for robot-assisted radical prostatectomy. Initially, all patients will receive general anesthesia and will then be randomly divided into three groups of 35 patients each to undergo bilateral transverse abdominal plane (TAP) block under aseptic conditions. This involves insertion of a needle into the plane between the internal oblique and transverse abdominal muscles under ultrasound guidance in order to inject the local anesthetic solution, as the responsible nerves run through the muscles of the abdominal wall. Specifically, 35 patients will receive only local anesthetic (ropivacaine), 35 will receive ropivacaine plus tramadol, and 35 will receive ropivacaine plus magnesium. Neither the researchers nor the participants will be aware of the composition of the solution administered (double-blind randomized controlled trial). The two co-primary endpoints are: (1) intraoperative fentanyl consumption, guided by the Nociception Level (NOL) index, and (2) postoperative pain intensity assessed by the Numeric Rating Scale (NRS, 0-10) at 8 time points within the first 24 hours (at 5, 15, 30, and 60 minutes in the Post-Anesthesia Care Unit and at 2, 4, 8, and 24 hours on the ward, both at rest and on coughing), analysed by global repeated measures ANOVA. Secondary endpoints include total rescue tramadol consumption and time to first rescue dose in the first 24 postoperative hours, sedation level assessed by the Ramsay Sedation Scale and peripheral oxygen saturation (SpO₂) as safety parameters, and the incidence of postoperative nausea and vomiting (PONV). In addition, researchers will contact participants at 1, 3, and 6 months postoperatively to assess chronic pain. The sample size was determined by a pre-planned interim analysis (n=30): the fentanyl endpoint requires n=35 per group (N=105 total) to achieve 80% power (Cohen's f=0.308, α=0.05). The study will be conducted at Aretaieio University Hospital in Athens under the supervision of Anesthesiology Professors. There are no additional risks or costs beyond those normally associated with radical prostatectomy, as TAP block has already been adopted as an analgesic method at Aretaieio Hospital.

Official title: Effect of Tramadol or Magnesium in Local Anesthetic Solution on Ultrasound-guided Bilateral TAP Block During Robotic Radical Prostatectomy on Acute Perioperative Pain and Chronic Postoperative Pain.

Key Details

Gender

MALE

Age Range

40 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

105

Start Date

2025-12-09

Completion Date

2028-12-10

Last Updated

2026-10-09

Healthy Volunteers

No

Interventions

OTHER

Ultrasound - guided bilateral transversus abdominis plane block (TAP) in patients undergoing robotic-assisted radical prostatectomy.

105 patients will be enrolled and divided in three different groups receiving U/G bilateral TAP block under aseptic conditions after induction of anesthesia and before the beginning of the surgery. The three groups of 35 patients each will differ in terms of the composition of the solution administered to them, in order to investigate any effect of 100mg tramadol or 300mg magnesium on the duration and the quality of the field block provided by ropivacaine injection. Both the total volume of the solution and the total amount of ropivacaine administered to all patients will be practically the same. Epinephrine will also be added to the local anesthetic solution so that the concentration will be 1:200,000. First of all, all the patients will receive general anesthesia and they will not differ in any way in terms of the doses (mg/kg) of medication they will receive for induction of anesthesia (according to their weight).

Locations (1)

Aretaieion University Hospital of Athens

Athens, Attica, Greece